Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.

TitleSerum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.
Publication TypeJournal Article
Year of Publication2023
AuthorsChen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R
JournalInflamm Bowel Dis
Volume29
Issue9
Pagination1499-1503
Date Published2023 Sep 01
ISSN1536-4844
KeywordsAntibodies, Monoclonal, Crohn Disease, Humans, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Remission Induction, Treatment Outcome, Ustekinumab
DOI10.1093/ibd/izac236
Alternate JournalInflamm Bowel Dis
PubMed ID36421052

Weill Cornell Medicine Friedman Center for Nutrition & Inflammation 413 E. 69th Street, Seventh Floor New York, NY 10021